CiceroDx

Cicero Diagnostics is proud to be featured in ’s new national campaign highlighting the role of endometriosis in infertility.
Learn more by checking out the entire digital campaign:
https://www.futureofpersonalhealth.com/campaign/future-of-fertility/
or our two featured articles by Dr Aimee MD, MPH, Fertility Expert and Dr. Dan Martin, MD, Scientific and Medical Director, Endometriosis Foundation of America. Links below:
https://www.futureofpersonalhealth.com/future-of-fertility/an-expert-explains-endometriosis/

https://www.futureofpersonalhealth.com/future-of-fertility/the-underexamined-problem-of-endometriosis/

Endometriosis: An Underexamined Problem - Future of Personal Health The scientific and medical director of the Endometriosis Foundation of America, Dr. Dan Martin, MD, explains why endometriosis often goes undiagnosed for so long, and what patients and providers can do about it.

This huge milestone signifies substantial test growth and reflects the role ReceptivaDx now plays as a new standard of care in fertility centers.

Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ Test Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ Test

Cicero Diagnostics is excited to partner with on its Maternal Health campaign launched digitally and through USA today. While the campaign looks to raise the conversation on reproductive technology, accessibility to care, and overall maternal wellness throughout the stages of pregnancy, Cicero Diagnostics continues to focus on the struggle’s women using or considering IVF may experience. Read our short educational approach to finding the right center for you https://www.futureofpersonalhealth.com/maternal-health/when-contemplating-ivf-educate-and-advocate/

Learn more by checking out the entire digital campaign in USA Today and online at:
https://www.futureofpersonalhealth.com/campaign/maternal-health/

Considering IVF? Educate and Advocate - Future of Personal Health Despite great advances in IVF technologies, the success rates of a live birth are still only slightly higher than 50 percent. So, what can you do to increase those odds?

As more women seek information on ReceptivaDx for unexplained infertility and pregnancy loss, our new app adds value for both physician staff and patients.

Cicero Diagnostics Introduces Fertility App for ReceptivaDx As more women seek information on ReceptivaDx for unexplained infertility and pregnancy loss, new app adds value for physician staff and patients.

Cicero Diagnostics is proud to contribute to National Women's Health Week encouraging women to make their health a priority. In the area of reproductive health, Cicero Diagnostics and our signature test ReceptivaDx continue to make a significant positive impact on women having trouble conceiving or sustaining a pregnancy. We may have the answer. Learn more at www.receptivadx.com

ReceptivaDx testing is now used routinely in 80% of all Fertility Centers in the US to help resolve failed implantation and recurrent pregnancy loss.

Cicero Diagnostics Hits Record Growth For First Quarter 2021 Cicero Diagnostics Hits Record Growth For First Quarter 2021; 700+ Reproductive Endocrinologists, 80% of US fertility sites now access ReceptivaDx™

Don't forget to join us this Sunday, October 25th!

Cicero Diagnostics Announces its Scientific Advisor, Dr. Bruce Lessey, Will Be Featured at The Endometriosis Summit Event During Virtual Fertility Weekend | BioSpace Cicero Diagnostics Announces its Scientific Advisor, Dr. Bruce Lessey, Will Be Featured at The Endometriosis Summit Event During Virtual Fertility Weekend - read this article along with other careers information, tips and advice on BioSpace

Join us on October 24-25th for the Virtual Endometriosis Summit! Dr. Bruce Lessey’s talk “Strategies for improving outcomes through early detection of endometriosis in the infertility clinic,” is scheduled at 3pm EST on Sunday the 25th.

Visit the website below for more information and how to register.

Virtual Fertility Weekend Bring an end to the stigma and isolation. Find the reason driving fertility struggles. Connect to others. Understand Infertility. End the trauma. Build your family

Thanks, ReceptivaDx, for sending your superhero to our office. We're knocking out unexplained infertility together. BAM! POW! 💥💪🏼

Outcomes data continues to support the value of the ReceptivaDx test!

Fertility and Sterility Publishes Largest Outcomes Research to Date on Cicero Diagnostic’s BCL6 Protein Test for Unexplained Infertility Cicero Diagnostics, Inc., the provider of the ReceptivaDx test, today announced that outcomes data from research that followed the progress of 189 IVF